VIOL's Scarlet Pro radiofrequency microneedling system has received FDA 510(k) clearance as substantially equivalent (product code GEI, general/plastic surgery). The device joins an increasingly crowded RF microneedling segment dominated by Cutera's Secret Pro, Inmode's Fractora, and Candela's Profound.
Devices & Tech
VIOL Scarlet Pro Wins FDA 510(k) Clearance
South Korean RF microneedling device clears U.S. market as competition intensifies.
1-YEAR MOVE
INMD
▲1.0%
| Ticker | Company | 1-year change |
|---|---|---|
| INMD | InMode Ltd. | +1.0% |
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
VIOL's Scarlet Pro clears FDA as RF microneedling market grows crowded.
Scarlet Pro's clearance matters less for innovation than for market saturation. RF microneedling has become commoditized in the U.S. market—practices choose based on needle depth, temperature profile, and pricing rather than clinical differentiation. VIOL's entry suggests the Korean device makers see margin opportunity in the U.S. channel, likely competing on acquisition cost and rebate programs rather than clinical claims.
Source: original report ↗
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.